[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)] [Notices] [Pages 57094-57095] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2012-22784] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2012-D-0881] Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Monday, August 27, 2012 (77 FR 51811). The document announced a draft guidance for industry entitled ``Self-Identification of Generic Drug Facilities, Sites, and Organizations.'' The document was published with an incorrect docket [[Page 57095]] number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2012-20946, appearing on page 51811 in the Federal Register of Monday, August 27, 2012, the following correction is made: 1. On page 51811, in the third column, the docket number is corrected to read ``FDA-2012-D-0881''. Dated: August 30, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012-22784 Filed 9-14-12; 8:45 am] BILLING CODE 4160-01-P